These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 11919228)
1. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. Nagtegaal ID; van de Velde CJ; van der Worp E; Kapiteijn E; Quirke P; van Krieken JH; J Clin Oncol; 2002 Apr; 20(7):1729-34. PubMed ID: 11919228 [TBL] [Abstract][Full Text] [Related]
2. Product analysis and initial reliability testing of the total mesorectal excision-quality assessment instrument. Simunovic MR; DeNardi FG; Coates AJ; Szalay DA; Eva KW Ann Surg Oncol; 2014 Jul; 21(7):2274-9. PubMed ID: 24590437 [TBL] [Abstract][Full Text] [Related]
3. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
5. Quality assurance in rectal cancer treatment. van de Velde CJ; van den Broek CB Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944 [TBL] [Abstract][Full Text] [Related]
6. Pathologic evaluation of total mesorectal excision: big brother is watching. Rodriguez-Bigas MA J Clin Oncol; 2002 Apr; 20(7):1714-5. PubMed ID: 11919224 [No Abstract] [Full Text] [Related]
7. Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma. Tzardi M Dig Dis; 2007; 25(1):51-5. PubMed ID: 17384508 [TBL] [Abstract][Full Text] [Related]
8. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. Parfitt JR; Driman DK J Clin Pathol; 2007 Aug; 60(8):849-55. PubMed ID: 17046842 [TBL] [Abstract][Full Text] [Related]
9. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587 [TBL] [Abstract][Full Text] [Related]
10. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer. Leite JS; Martins SC; Oliveira J; Cunha MF; Castro-Sousa F Colorectal Dis; 2011 Apr; 13(4):381-6. PubMed ID: 20002696 [TBL] [Abstract][Full Text] [Related]
12. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. García-Granero E; Faiz O; Muñoz E; Flor B; Navarro S; Faus C; García-Botello SA; Lledó S; Cervantes A Cancer; 2009 Aug; 115(15):3400-11. PubMed ID: 19479978 [TBL] [Abstract][Full Text] [Related]
13. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Kapiteijn E; Putter H; van de Velde CJ; Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic vs open total mesorectal excision for rectal cancer: an evaluation of the mesorectum's macroscopic quality. Breukink SO; Grond AJ; Pierie JP; Hoff C; Wiggers T; Meijerink WJ Surg Endosc; 2005 Mar; 19(3):307-10. PubMed ID: 15624051 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis. Lu JY; Lin GL; Qiu HZ; Xiao Y; Wu B; Zhou JL PLoS One; 2015; 10(10):e0141427. PubMed ID: 26505895 [TBL] [Abstract][Full Text] [Related]
17. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ; Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Martling A; Singnomklao T; Holm T; Rutqvist LE; Cedermark B Br J Surg; 2004 Aug; 91(8):1040-5. PubMed ID: 15286968 [TBL] [Abstract][Full Text] [Related]
19. Do supervised colorectal trainees differ from consultants in terms of quality of TME surgery? Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE Colorectal Dis; 2006 Nov; 8(9):790-4. PubMed ID: 17032327 [TBL] [Abstract][Full Text] [Related]
20. Scoring the quality of total mesorectal excision for the prediction of cancer-specific outcome. Leonard D; Penninckx F; Laenen A; Kartheuser A; Colorectal Dis; 2015 May; 17(5):O115-22. PubMed ID: 25714054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]